anti-Bacterial Innovative Vaccine Training Network.

Project Information

BactiVax

Grant agreement ID: 860325

DOI 10.3030/860325

Project closed

EC signature date 19 August 2019

Start date 1 October 2019

End date 31 March 2024

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 4 009 372,56

EU contribution € 4 009 372,56

Coordinated by

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Ireland

Deliverables

Websites, patent fillings, videos etc. (2)

Social media campaign & Podcast BactiVax Web-site

Social media campaign Podcast BactiVax Website The campaign will run throughout the project from M4 to M48 The podcasts will be due on M20 and M47

BactiVax LinkedIn group

BactiVax LinkedIn Group established and all members of the consortium following the group LMU will lead this and will be supported by CNRIBB

Documents, reports (3)

Protocols: novel NMR methods to explore molecu-lar recognition processes to target

Protocols novel NMR methods to explore molecular recognition processes to target mechanism of action of TLR agonists There will be two drafts of the protocols at month 24 and 36

Report on Vaccine advocacy activities

Reports on Vaccine advocacy activities will be prepared annually at 9 21 33 and 45 months

Communication and Public engagement Plan

Communication and Public Engagement strategy developed and circulated to BactiVax network

Open Research Data Pilot (1)

Plan for the Exploitation and Dissemination of results (PEDR) plan

Plan for the Exploitation and Dissemination of results PEDR in place

Publications

Peer reviewed articles (12)

Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis

Author(s): Daria Augustyniak, Eliza Kramarska, Paweł Mackiewicz, Magdalena Orczyk-Pawiłowicz, Fionnuala T. Lundy
Published in: International Journal of Molecular Sciences, Issue 22(7), 2021, ISSN 1422-0067
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms22073658

PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells

Author(s): Flavio De Maio, Alessandro Salustri, Basem Battah, Ivana Palucci, Federica Marchionni, Silvia Bellesi, Valentina Palmieri, Massimiliano Papi, Eliza Kramarska, Maurizio Sanguinetti, Michela Sali, Rita Berisio, and Giovanni Delogu.
Published in: Virulence, Issue Volume 13, Issue 1, 2022, Page(s) 868-884, ISSN 2150-5608
Publisher: Taylor & Francis
DOI: 10.1080/21505594.2021.1897247

Solid-phase peptide synthesis on disulfide-linker resin followed by reductive release affords pure thiol-functionalized peptides

Author(s): Bognar, Zsolt ; Mothukuri, Ganesh K. ; Nielsen, Alexander L. ; Merz, Manuel L. ; Panzar, Peter M. F. ; Heinis, Christian
Published in: Organic & Biomolecular Chemistry, 2022, Page(s) 5699-5703, ISSN 1477-0520
Publisher: Royal Society of Chemistry
DOI: 10.1039/d2ob00910b

Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development

Author(s): Samuel T Pasco and Juan Anguita
Published in: Cells, Issue 9, 2020, Page(s) E2109, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells9092109

Current Status on Therapeutic Molecules Targeting Siglec Receptors

Author(s): María Pia Lenza, Unai Atxabal, Iker Oyenarte, Jesús Jiménez-Barbero, June Ereño-Orbea
Published in: Cells, Issue 9/12, 2020, Page(s) 2691, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells9122691

Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis

Author(s): Chiara Bellini and Kata Horváti
Published in: Cells, Issue 9/12, 2020, Page(s) 2673, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells9122673

Current Advances in Burkholderia Vaccines Development

Author(s): Guanbo Wang, Paulina Zarodkiewicz, Miguel A. Valvano
Published in: Cells, Issue 9/12, 2020, Page(s) 2671, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells9122671

Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors

Author(s): Irene Jurado-Martín, Maite Sainz-Mejías, Siobhán McClean
Published in: International Journal of Molecular Sciences, Issue 22/6, 2021, Page(s) 3128, ISSN 1422-0067
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms22063128

Predictive and Experimental Immunogenicity of Burkholderia Collagen-like Protein 8-Derived Antigens

Author(s): Megan E. Grund, Eliza Kramarska, Soo Jeon Choi, Dudley H. McNitt, Christopher P. Klimko, Nathaniel O. Rill, Jennifer L. Dankmeyer, Jennifer L. Shoe, Melissa Hunter, David P. Fetterer, Zander M. Hedrick, Ivan Velez, Sergei S. Biryukov, Christopher K. Cote, Rita Berisio, Slawomir Lukomski
Published in: MDPI Vaccines, Issue 9(11), 2021, Page(s) 1219, ISSN 2076-393X
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines9111219

Understanding Pseudomonas aeruginosa–Host Interactions: The Ongoing Quest for an Efficacious Vaccine

Author(s): Maite Sainz-Mejías, Irene Jurado-Martín, Siobhán McClean
Published in: Cells, Issue 9/12, 2020, Page(s) 2617, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells9122617

PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host Humoral Immune Response

Author(s): Eliza Kramarska, Flavia Squeglia, Flavio De Maio, Giovanni Delogu, Rita Berisio
Published in: Cells, Issue 10/1, 2021, Page(s) 161, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells10010161

Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants

Author(s): Ana Rita Franco, Francesco Peri
Published in: Cells, Issue 10/1, 2021, Page(s) 78, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells10010078